OLIG2 (Oligodendrocyte transcription factor 2) is a pivotal transcription factor involved in the development and maturation of oligodendrocytes, the myelinating cells of the central nervous system. It plays a crucial role in neural development, particularly in the regulation of oligodendrocyte differentiation and the formation of the myelin sheath that insulates neuronal axons, facilitating rapid signal conduction. The expression and functional activity of OLIG2 are essential for proper neural circuitry and brain function, highlighting its significance in neural health and disease. The activation of OLIG2 is intricately tied to various signaling pathways, including those mediated by retinoic acid, cAMP, and growth factors, which influence its ability to drive the oligodendrocyte lineage's progression from progenitor cells to fully differentiated myelinating oligodendrocytes.
Mechanisms leading to the functional activation of OLIG2 involve a complex interplay of intracellular signaling cascades initiated by specific ligands and chemical activators. These activators can influence OLIG2 directly or indirectly by modulating the activity of upstream signaling molecules and transcription factors that govern OLIG2's expression levels and its phosphorylation state. For instance, the activation of cAMP-dependent protein kinase A (PKA) and the inhibition of GSK-3β are crucial for the modulation of transcription factors that directly impact OLIG2 activation. Similarly, signaling pathways triggered by BDNF, IGF-1, and T3 thyroid hormone play significant roles in promoting OLIG2's role in oligodendrocyte maturation and the maintenance of the myelin sheath. Understanding these pathways and the effects of specific chemical activators on OLIG2 activation offers valuable insights into the molecular mechanisms underlying oligodendrocyte development and function, as well as approaches for addressing demyelinating diseases and neural repair strategies.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, which can phosphorylate transcription factors involved in the expression and functional activation of OLIG2 in neural progenitor cells. | ||||||
Lithium Chloride | 7447-41-8 | sc-203110 sc-203110A sc-203110B sc-203110C sc-203110D sc-203110E | 50 g 250 g 1 kg 2.5 kg 5 kg 10 kg | $33.00 $110.00 $265.00 $500.00 $950.00 $1487.00 | 8 | |
Lithium Chloride inhibits GSK-3β, a kinase that phosphorylates and inhibits factors promoting OLIG2 activation. By inhibiting GSK-3β, Lithium Chloride stabilizes factors enhancing OLIG2's role in neural differentiation and myelination. | ||||||
Valproic acid sodium salt | 1069-66-5 | sc-202378A sc-202378 sc-202378B sc-202378C | 1 g 5 g 25 g 100 g | $21.00 $37.00 $131.00 $369.00 | 9 | |
Sodium Valproate acts as a HDAC inhibitor, leading to chromatin remodeling and increased accessibility of transcription factors to DNA, indirectly supporting OLIG2 activation through enhanced gene expression relevant to oligodendrocyte development. | ||||||
SC 26196 | 218136-59-5 | sc-361350 sc-361350A | 10 mg 50 mg | $158.00 $630.00 | 3 | |
BDNF mimetics activate TrkB receptors, initiating signaling cascades that culminate in the activation of cellular pathways promoting OLIG2 function in neuron survival and neural network formation. | ||||||
SAG | 912545-86-9 | sc-212905 sc-212905A | 1 mg 5 mg | $166.00 $421.00 | 27 | |
SAG directly activates the Smoothened receptor, part of the Hedgehog signaling pathway, which is crucial for OLIG2 activation and the regulation of neural stem cell proliferation and differentiation into oligodendrocytes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which then influences signaling pathways that lead to the phosphorylation and functional activation of OLIG2, facilitating its role in oligodendrocyte differentiation and maturation. | ||||||
L-3,3′,5-Triiodothyronine, Sodium Salt | 55-06-1 | sc-205725 | 250 mg | $115.00 | ||
T3 binds to thyroid hormone receptors, modulating gene expression patterns that enhance OLIG2 activation, crucial for the development and maturation of oligodendrocytes and myelin sheath formation in the central nervous system. | ||||||
Calcium dibutyryladenosine cyclophosphate | 362-74-3 | sc-482205 | 25 mg | $147.00 | ||
Dibutyryl cyclic AMP, a cAMP analog, elevates intracellular cAMP levels, activating PKA and subsequently enhancing OLIG2 phosphorylation and activation, promoting oligodendrocyte lineage progression and myelination. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. This elevation in cAMP activates PKA, which indirectly enhances OLIG2 activation, crucial for oligodendrocyte development and function. | ||||||